Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Aug 03, 2023
Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability
Read more
Scientific Article
/ Apr 28, 2023
Capsule filling for DPIs: Linking Process scales through advanced characterisation and Quality by Design
Read more
Scientific Article
/ Mar 09, 2022
Monofluoromethylation of complex pharmaceutical steroids using non-depleting reagents
Read more
Scientific Article